SYCP3 is a meiosis‐specific gene, but also expressed in several cancer types, in which it impairs mitotic recombination by interfering with BRCA2, sensitizing certain tumor cells to PARPis [40]; hence, we wanted to investigate this in TGCTs as well. The gene discussed is SYCP3; the disease is neoplasm.